organization
Evidence page

FDA Approves Remestemcel-L-Rknd for Steroid-Refractory Acute Graft-Versus-Host Disease in Pediatric Patients

Oncology Nursing Society

accessed Sep 18, 2026Updated Sep 19, 2026
Original source

https://www.ons.org/publications-research/voice/news-views/12-2024/fda-approves-remestemcel-l-rknd-steroid-refractory

ons.org

Verification

VerificationNot yet verified
Evidence level
Sourceorganization
Link statusReachable at last check

Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy

Cited by (7)